Alzheimer Testing at Silver Years

Early last year, the GenEthics Consortium (GEC) of the Washington Metropolitan Area convened at George Washington University to consider a complex case about genetic testing for Alzheimer disease (AD). The GEC consists of scientists, bioethicists, lawyers, genetic counselors, and consumers from a va...

Full description

Saved in:
Bibliographic Details
Published in:Cambridge quarterly of healthcare ethics 1998-07, Vol.7 (3), p.294-307, Article 294
Main Authors: THOMAS, A. MATHEW, COHEN, GENE, COOK-DEEGAN, ROBERT M., O'SULLIVAN, JOAN, POST, STEPHEN G., ROSES, ALLEN D., SCHAFFNER, KENNETH F., GREEN, RONALD M.
Format: Article
Language:English
Subjects:
Aged
Alleles
Alzheimer Disease - diagnosis
Alzheimer Disease - genetics
Apolipoproteins - genetics
Beneficence
Contracts
Disabled Persons - legislation & jurisprudence
Ethics
Female
Genetic Testing - legislation & jurisprudence
Genotype
Housing for the Elderly
Humans
Informed Consent
Male
Personal Autonomy
Predictive Value of Tests
Prejudice
Social Justice
United States
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Early last year, the GenEthics Consortium (GEC) of the Washington Metropolitan Area convened at George Washington University to consider a complex case about genetic testing for Alzheimer disease (AD). The GEC consists of scientists, bioethicists, lawyers, genetic counselors, and consumers from a variety of institutions and affiliations. Four of the 8 co-authors of this paper delivered presentations on the case. Supplemented by additional ethical and legal observations, these presentations form the basis for the following discussion.
ISSN:0963-1801
1469-2147
DOI:10.1017/S096318019870310X